<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE GlossaryTerm >
<GlossaryTerm id="CDR0000642135"><TermName>1-(2’-deoxy-2’-fluoro-β-D-arabinofuranosyl) uracil</TermName><TermPronunciation>(1-(2'-dee-OK-see-2'-FLOOR-oh-BAY-tuh-D-uh-RA-bih-noh-fyoor-A-noh-sil) YOOR-uh-sil)</TermPronunciation><TermDefinition><DefinitionText>A substance being studied in the treatment of advanced solid tumors and lymphomas. It blocks the growth of cells and may cause cancer cells to die. It is a type of uracil analog. Also called FAU.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></TermDefinition><MediaLink ref="CDR0000723011" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;1-(2’-deoxy-2’-fluoro-β-D-arabinofuranosyl) uracil&quot;" language="en" id="_3"/><MediaLink ref="CDR0000723010" type="audio/mpeg" alt="Pronunciation of dictionary term &quot;1-(2-desoxi-2-fluoro-β-D-arabinofuranosil)-uracilo&quot;" language="es" id="_4"/><SpanishTermName>1-(2-desoxi-2-fluoro-β-D-arabinofuranosil)-uracilo</SpanishTermName><SpanishTermDefinition><DefinitionText>Sustancia en estudio para el tratamiento de los tumores sólidos y linfomas en estadio avanzado. Impide el crecimiento de las células y podría destruir células cancerosas. Es un tipo de análogo del uracilo. También se llama FAU.</DefinitionText><Dictionary>Cancer.gov</Dictionary><Audience>Patient</Audience></SpanishTermDefinition><DateFirstPublished>2009-07-21</DateFirstPublished></GlossaryTerm>
